Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Evolving as the GLP-1 medication landscape expands to include new formulations, new indications, and more
Talking to my insurance company is not my idea of a good time, but insurance companies are as new to the world of GLP-1s as the rest of us are, and their policies are constantly changing
Obstructive sleep apnea particularly relevant given the FDA's December 2024 approval of tirzepatide specifically for obesity-related OSA also qualifies as a relevant comorbidity for patients in the BMI 27 to 29.9 range
Water retention Some puffiness or bloating, especially in hands and face, as IGF-1 causes cells to hold more water
Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
TRIUMPH Phase 3
US$ 21.66
US$ 24.04
US$ 26.54
